OptiNose, Inc. announced preliminary XHANCE net product revenue results for the first quarter ended March 31, 2024. for the quarter, the company reported preliminary XHANCE net product revenue of $14.9 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.155 USD | +8.96% |
|
+5.96% | -10.47% |
May. 20 | OptiNose, Inc. announced that it has received $4.68 million in funding | CI |
May. 14 | Transcript : OptiNose, Inc., Q1 2024 Earnings Call, May 14, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.47% | 154M | |
+47.09% | 765B | |
-6.73% | 354B | |
+19.25% | 331B | |
+8.71% | 299B | |
+18.83% | 248B | |
-1.96% | 219B | |
+10.90% | 216B | |
+5.02% | 164B | |
-2.59% | 162B |
- Stock Market
- Equities
- OPTN Stock
- News OptiNose, Inc.
- Optinose, Inc. Announces Preliminary XHANCE Net Product Revenue Results for the First Quarter Ended March 31, 2024